PKM and neoplasm: Tumor‐derived factors stimulate MDSCs with high‐level ROS to maintain their immunosuppressive function.[33] Here, we invented an l‐Phe‐based polymer, MRIAN, which specifically targeted MDSCs and degraded into l‐Phe to inhibit PKM2 activity, suppress glucose metabolism, and reduce the ROS levels in MDSCs.